Metabolic and Weight Management Study
Take part in a new research study for a potential new treatment for metabolic conditions.
This study aims to evaluate the safety and effectiveness of a potential new treatment for Metabolic conditions such as Obesity and Diabetes.
Critical Eligibility Criteria:
To take part in this study, you will need to meet all the following:
- Aged 18 to 65 years old
- BMI between 30 and 40
- Considered generally healthy
- Able to commit to the study schedule which includes a 30 night inpatient stay.
Commitment:
Participation is expected to last 71 days. This includes:
- 1 visit to the clinic that includes a physical screening with potential for a secondary visit for a Dexa scan.
- 30 night inpatient stay (at clinic)
- 1 follow up visit following the inpatient period.
Locations:
Adelaide
If you take part in this research study, there will be:
Reimbursement of costs
For out-of-pocket expenses, such as travel and parking.
Convenience
30 night inpatient stay that allows for possibility of remote work and visitors in discussion with the study site. Singular visits located at the same clinic
Free study-related medical care
Be among the first to access potential new research treatments before they are widely available.
Expert medical monitoring
Receive top-tier medical care and monitoring from experienced healthcare professionals.
Contribution to medical research
Help investigate a potential new treatment that could improve the lives of individuals with Metabolic Conditions.
Register your interest now
or scroll down to read the study FAQs
Study Guide
01
Who can take part in this study?
-
To take part in this study, you will need to meet all the following (other criteria apply):
- Aged between 18-65
- BMI between 30.0-40.0
- Considered generally healthy
- Able to commit to the study schedule which includes a 31 day inpatient stay
02
Who is unable to take part in this study?
+
Unfortunately, if any of the following apply to you, this study is not the right fit for you:
- If you have taken a GLP-1, GLP-2 or DPP-IV Inhibitor drug previously
- Are currently pregnant, breastfeeding, lactating or planning to fall pregnant during the study
- Have planned surgery during the study or surgery within the last 3 months.
- Have any condition or have had previous surgery that affects GI digestion, small intestine or colon as well as any history or gallstones, gallbladder disorders or gall bladder removal.
Please note, additional eligibility criteria apply.
03
What does the study involve for participants?
+
If the study is deemed suitable for you, your participation is expected to last approximately 71 days. This includes:
- 1 visit to the clinic that includes a physical screening with potential for a secondary visit for a Dexa scan
- 30 night inpatient stay (at clinic)
- 1 follow up visit following the inpatient period.
Participation in this research is voluntary, and you may withdraw from the study at any time.
04
What is the purpose of this study?
+
This study aims to evaluate a potential new treatment for Metabolic conditions such as Obesity and Diabetes and for people who may be impacted by Metabolic Syndrome.
05
What is Metabolic Syndrome?
+
Metabolic Syndrome is a cumulation of representative risk factors that are associated with metabolic conditions such as blood pressure, insulin resistance, obesity, diabetes and colitis.
06
Why is this study important?
+
This study is important because it is aiming to support and improve the effects of metabolic conditions by treating the underlying factors which can be associated with many potential conditions including obesity, diabetes and colitis.
07
Who is sponsoring this study?
+
This study is being sponsored by Metis Pharmaceuticals.
08
Where is my nearest study site?
+
Here is a list of all of the sites who are currently recruiting for this study:
-
CMAX Clinical Research, Ground Floor, 21/24 North Terrace, Adelaide SA 5000
09
What if I have other questions about the study?
+
We are here for you! Head to our Evrima Help Centre and search for answers relating to clinical trials, study information and managing your Evrilink account
This study has been approved by an independent Human Research Ethics Committee
Help make medical research breakthroughs happen.
Need help with clinical trial information?
Search our Evrima help Centre for answers related to information about our active studies, information about managing your Evrilink account, and general clinical trial knowledge!
Read our FAQs